Zhening F. Zhang
Key Laboratory Of Carcinogenesis And Translational Research
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Low-dose IL-2 therapy for immune-related adverse events via Tfh/Treg balance modulation: a prospective cohort and murine model study.
Journal: Cancer immunology, immunotherapy : CII
Published: January 25, 2026
Baseline profile peripheral Tfh cells predict immune-related adverse events in immune checkpoint inhibitor therapy of gastrointestinal cancer.
Journal: Frontiers in immunology
Published: January 12, 2025
Immune checkpoint inhibitors or anti-claudin 18.2 antibodies? A network meta-analysis for the optimized first-line therapy of HER2-negative gastric cancer.
Journal: Therapeutic advances in medical oncology
Published: October 13, 2023
Next stage of collaboration in East Asia gastric cancer treatment.
Journal: Chinese clinical oncology
Published: April 14, 2023
Time to surgery does not affect oncologic outcomes in locally advanced gastric cancer after neoadjuvant chemotherapy: a meta-analysis.
Journal: Future oncology (London, England)
Published: March 15, 2023
Recurrent Cystitis Associated With 2 Programmed Death 1 Inhibitors: A Rare Case Report and Literature Review.
Journal: Journal of immunotherapy (Hagerstown, Md. : 1997)
Published: October 23, 2022
Chinese expert consensus on management of dyslipidemia in the elderly
Journal: Zhonghua nei ke za zhi
Published: October 08, 2022
Extracellular Vesicle-Derived Protein File from Peripheral Blood Predicts Immune-Related Adverse Events in Gastric Cancer Patients Receiving Immunotherapy.
Journal: Cancers
Published: August 10, 2022
Does first-line immunotherapy impact the efficacy of later treatments: a discussion on the use of second progression-free survival as a research endpoint.
Journal: Journal of cancer research and clinical oncology
Published: April 20, 2022
Comparison of Treatment Efficacy and Survival Outcomes Between Asian and Western Patients With Unresectable Gastric or Gastro-Esophageal Adenocarcinoma: A Systematic Review and Meta-Analysis.
Journal: Frontiers in oncology
Published: December 08, 2021
Last Updated: 09/26/2026